Anabolic steroids started as a medical treatment, decades before anyone was using them to build muscle in a gym. The path from laboratory to locker room runs through Cold War politics, Olympic scandal, and a regulatory reaction that’s still shaping the law today.
The Discovery of Testosterone
German chemist Adolf Butenandt and Croatian-Swiss chemist Leopold Ruzicka independently synthesized testosterone in 1935, work that earned them a joint Nobel Prize in Chemistry in 1939. The original goal was medical: a treatment for hypogonadism and other conditions involving low natural testosterone. Within a few years, researchers were already testing modified versions designed to build muscle tissue more efficiently while dialing back masculinizing side effects.
Cold War Competition Drives Development
The turning point for sport came out of Cold War rivalry rather than medicine. Soviet weightlifters dominated the 1952 Helsinki Olympics, and by the 1954 World Weightlifting Championships, a Soviet team physician reportedly told his American counterpart, Dr. John Ziegler, that the Soviet athletes were using testosterone. Ziegler returned to the United States and began working with Ciba Pharmaceuticals to develop an American answer.
That work produced methandrostenolone, marketed by Ciba starting in 1958 as Dianabol. It spread quickly through American weightlifting and bodybuilding circles, and by the 1960s, steroid use had become common practice in strength sports on both sides of the Cold War divide. East Germany later built a state-sponsored doping program around its Olympic athletes, one of the most extensive in sports history.
Sport Starts Testing
Steroid testing at the Olympics began in the 1970s, once analytical chemistry caught up enough to detect the compounds reliably. The most well-known consequence came at the 1988 Seoul Olympics, when Canadian sprinter Ben Johnson was stripped of his 100-meter gold medal after testing positive for stanozolol. The case became a defining moment in anti-doping enforcement and pushed steroid use into mainstream public conversation for the first time.
Regulation Catches Up
Steroid use in gyms had outpaced steroid law for decades. That started to change in 1990, when the United States passed the Anabolic Steroid Control Act, formally classifying anabolic steroids as controlled substances rather than leaving them regulated the way ordinary prescription drugs were. Canada’s own framework, placing anabolic steroids under Schedule IV of the Controlled Drugs and Substances Act, developed along a similar trajectory, treating the compounds as controlled but distinct from narcotics.
From Steroids to a Broader Market
The decades since have seen the market diversify well beyond the original testosterone derivatives. SARMs emerged as compounds designed to target muscle and bone tissue more selectively than steroids, without full authorization for human use in Canada or the US. Peptides, originally developed for specific clinical purposes like growth hormone regulation, found their own audience among people looking for alternatives to traditional steroids, with a different mechanism and a different regulatory status.
Why the History Still Matters
The regulatory patchwork that governs anabolic steroids today, personal possession treated differently from trafficking, SARMs sitting in a gray zone, peptides split across multiple categories, isn’t arbitrary. Each piece traces back to a specific moment: a medical discovery, a Cold War response, a doping scandal, a legislative reaction. Understanding that history explains why the current rules look the way they do, and why enforcement still focuses more on supply than on the person holding the product. Readers curious about how a specific product fits today’s rules can always reach out directly.
